Secondary Logo

Journal Logo

HIV criminalization exacerbates subpar diagnosis and treatment across the United States

response to the ‘Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States’

Sah, Prathaa; Fitzpatrick, Meagan C.b; Pandey, Abhishekc; Galvani, Alison P.c,d

doi: 10.1097/QAD.0000000000001636
Correspondence
Free

aDepartment of Biology, Georgetown University, Washington, District of Columbia

bCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland

cCenter for Infectious Disease Modeling and Analysis, Yale School of Public Health

dDepartment of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, USA.

Correspondence to Dr Alison P. Galvani, Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, Connecticut, USA. E-mail: alison.galvani@yale.edu

Received 16 August, 2017

Accepted 25 August, 2017

In their article ‘Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States’, Sweeney et al.[1] find no association between a state's criminal exposure laws and the rates of HIV or AIDS diagnosis. Thirty-three states in the United States have implemented laws criminalizing behaviours, including needle sharing and sexual contact, that could put others at risk of transmission [2]. As highlighted by Sweeney et al.[1], the public health impact of these laws should be assessed. However, it was not considered that the annual number of diagnoses alone is uninformative without taking into account epidemiological trajectories. If an epidemic is growing, a constant number of annual diagnoses would actually correspond to a reduced rate of diagnosis among people living with HIV (PLHIV). Conversely, the number of diagnoses may remain constant as an epidemic is brought under control if the percentage of PLHIV diagnosed increases. In fact, these inverse associations would be expected. Given that diagnosis is an integral component of treatment-as-prevention strategies, higher rates of diagnosis should be associated with curtailing of HIV epidemics.

We conducted the analysis described in Sweeney et al.[1], but stratified the diagnosis rate into two response variables: the proportion of PLHIV diagnosed and annual percentage change in HIV prevalence. The data required for the replication of the results, and the relevant analysis code, are provided at https://github.com/prathasah/US-law-and-HIV. All socioeconomic factors described in [1] were used as explanatory variables. As our first outcome normalized the total HIV diagnoses with the number of PLHIV (instead of the population size), we included population sizes of states as an additional explanatory variable in our model. Here, we present the results of the full models with all explanatory variables, and the subset of predictors that best explain the response variables (Table 1).

Table 1

Table 1

Counter to the conclusions of Sweeney et al., our analyses indicate that laws criminalizing HIV exposure are associated with lower proportion of HIV diagnosis (full model:

, P = 0.016; subset model:

, P = 0.009) and increased HIV prevalence (full model:

, P = 0.04; subset model:

, P = 0.011). Educational attainment is associated with declining HIV prevalence and higher diagnosis rates. State population size and urbanicity are associated with higher proportions of PLHIV diagnosed and increasing prevalence, respectively.

As the authors and others have argued [1,3], laws criminalizing HIV exposure can deter people from seeking diagnosis. Given the effectiveness of current antiretrovirals in preventing HIV transmission, diagnosis and treatment are fundamental to both improving individual health outcomes as well as protecting others. Our analyses here underscore the importance of distinguishing between the impact of laws on HIV diagnosis and HIV transmission, as their combined effect on HIV diagnosis rate could be confounding and misleading. Our evaluations of these distinct outcomes demonstrate that laws criminalizing HIV exposure have a negative association with HIV testing and a positive association with increasing HIV prevalence. Consequently, these laws may be exacerbating HIV transmission, as advocates for legal reform have argued [4]. Our results are consistent with studies that have documented the ramifications of HIV criminalization [5–7]. Our analyses demonstrate that laws criminalizing HIV exposure are not only ineffective, but counterproductive.

Back to Top | Article Outline

Acknowledgements

M.C.F. was supported by National Institutes of Health grant T32 AI007524. A.P. and A.P.G. were supported by National Institutes of Health grants U01 GM105627 and U01 GM087719.

Back to Top | Article Outline

Conflicts of interest

There are no conflicts of interest.

Back to Top | Article Outline

References

1. Sweeney P, Gray SC, Purcell DW, Sewell J, Babu AS, Tarver BA, et al. Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States. AIDS 2017; 31:1483–1488.
2. Stan Lehman J, Carr MH, Nichol AJ, Ruisanchez A, Knight DW, Langford AE, et al. Prevalence and public health implications of state laws that criminalize potential HIV exposure in the United States. AIDS Behav 2014; 18:997–1006.
3. Galletly CL, Pinkerton SD. Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIV. AIDS Behav 2006; 10:451–461.
4. McClelland A, French M, Mykhalovskiy E, Gagnon M, Manning E, Peck R, et al. The harms of HIV criminalization: responding to the ‘association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States’. AIDS 2017; 31:1899–1900.
5. Lee SG. Criminal law and HIV testing: empirical analysis of how at-risk individuals respond to the law. Yale J Health Policy Law Ethics 2014; 14:194–238.
6. Adam BD, Elliott R, Corriveau P, English K. Impacts of criminalization on the everyday lives of people living with HIV in Canada. Sex Res Soc Policy 2014; 11:39–49.
7. Bernard EJ, Cameron S. Advancing HIV Justice 2: building momentum in global advocacy against HIV criminalisation. Brighton/Amsterdam: Justice Network and GNP+; 2016.
Copyright © 2017 Wolters Kluwer Health, Inc.